ANDRIEU-ABADIE; Nathalie

Patent Applications and Registrations

Patent applications and USPTO patent grants for ANDRIEU-ABADIE; Nathalie.The latest application filed is for "use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer".

Company Profile

8.4.8

ANDRIEU-ABADIE; Nathalie - Toulouse FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Sk2 Inhibitors In Combination With Immune Checkpoint Blockade Therapy For The Treatment Of Cancer App 20220160692 - GHENASSIA; Alexandre ; et al.	2022-05-26
Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer Grant 11,078,277 - Levade , et al. August 3, 2	2021-08-03
Methods And Pharmaceutical Composition For The Treatment Of Cancer App 20210145977 - LEVADE; Thierry ; et al.	2021-05-20
Use Of Sk1 As Biomarker For Predicting Response To Immunecheckpoint Inhibitors App 20210080467 - COLACIOS VIATGE; Celine ; et al.	2021-03-18
Methods and pharmaceutical composition for the treatment of cancer Grant 10,918,737 - Levade , et al. February 16, 2	2021-02-16
Methods For Enhancing The Potency Of The Immune Checkpoint Inhibitors App 20210040215 - LEVADE; Thierry ; et al.	2021-02-11
Methods for enhancing the potency of the immune checkpoint inhibitors Grant 10,822,415 - Levade , et al. November 3, 2	2020-11-03
Methods And Pharmaceutical Composition For The Treatment Of Cancer App 20190038763 - LEVADE; Thierry ; et al.	2019-02-07
Methods And Pharmaceutical Compositions For Enhancing Cd8+ T Cell-dependent Immune Responses In Subjects Suffering From Cancer App 20190031756 - LEVADE; Thierry ; et al.	2019-01-31
Methods For Enhancing The Potency Of The Immune Checkpoint Inhibitors App 20190031757 - LEVADE; Thierry ; et al.	2019-01-31
Method for treating melanoma Grant 10,144,772 - Segui , et al. De	2018-12-04
New Method For Treating Melanoma App 20170174744 - SEGUI; Bruno ; et al.	2017-06-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.